CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Drug Discovery

  • Events
  • Researchers
  • GLP
  • GMP
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
3 March 2025 Event Date: 10 February 2025 −

Workshop Report: Introduction to 4D-Nucleofector Technology

A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research.

20250210 123113
  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Laboratory
  • Marketaccess
  • Pre Clinical
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
2 October 2024 Event Date: 18 October 2024 −

Program Announcement CTGCT Conference, 18th Oct 2024

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

Featured Up Regulation
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects
  • Interview
  • Researchers
  • Datamanagement
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
27 June 2024

Interview with Shivang Khandewal – collaborator of NIC and CTNNB1

Originally from India, Shivang Khandelwal is presently engaged in advanced studies at the Hebrew University of Jerusalem. His primary research focus is on PCDH19 cluster epilepsy, a neurodevelopmental and neuropsychiatric disorder. He is deeply ...

Shivang Khandelwal
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Drug Discovery
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
27 June 2024

Bespoke Gene Therapy Consortium – cooperation for rare disease therapies

At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • GMP
  • Clinic study
  • Datamanagement
  • Drug Discovery
  • Ethicalcommittee
  • Investment
  • Laboratory
  • Logistics
  • Manufacturing Process
  • Modalitetadelovanjazdravila
  • Pharmacodynamics
  • Pharmacokinetics
  • Pre Clinical
  • Raw Material
  • Regulation
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00

CTNNB1 Conference – One Year to Cure

One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ...

  • Articles
  • Researchers
  • Drug Discovery
  • Research
  • NIC
  • Mojca Bencina
20 June 2024

Protein Gas Vesicles – Potential to Improve Therapy, published in ACS Nano

Ultrasound is a useful method in diagnostics, as it enables a deep and non-invasive observation of the body. Under certain conditions, ultrasound can stimulate cells, but this effect is very small and to amplify ...

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna